Exceptionally Robust Asthma Pipeline with More Than 100+
Asthma is considered to be one of the world's most common diseases affecting the population, and is also a life-threatening condition affecting patients'...
Source: globenewswire.com
Page 6 - Positive Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Positive Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Positive Phase Today - Breaking & Trending Today
Guggenheim Securities
Twitter Inc (NYSE: TWTR) shares made a strong comeback in 2018, ending the year with nearly a 20-percent advance and outperforming social media peers. The short-messaging platform has built on the gains with a 14.4-percent advance in the first quarter of 2019. That's smaller than Facebook,... Read More...
Source: benzinga.com
iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
The FDA approved an expansion in the label for Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) immunotherapy Libtayo for treating patients with advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor, HHI, or for whom an HHI is not appropriate. Full approval was granted for patients with locally advanced BCC and accelerated approval was granted for patients with metastatic BCC. Moderna Strikes Vaccine Supply Agreements With Taiwan and Columbia Moderna Inc (NASDAQ: MRNA) announced two supply agreements for its COVID-19 Vaccine - one with ...
Source: benzinga.com
Redirecting to Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
717.5 -3.8% (1) Further information on certain of Takeda’s Non-IFRS measures is posted on Takeda’s investor relations website at https://www.takeda.com/investors/reports/quarterly-announcements/ (2) Underlying growth compares two periods (quarters or years) of financial results under a common basis and is used by management to assess the business. These financial results are calculated on a constant currency basis and excluding the impact of divestitures and other amounts that are unusual, non-recurring items or unrelated to our ongoing operations. (3) Core Operating Profit represents ...
Source: q8dailynews.com
Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
(1) Further information on certain of Takeda’s Non-IFRS measures is posted on Takeda’s investor relations website at (2) Underlying growth compares two periods (quarters or years) of financial results under a common basis and is used by management to assess the business. These financial results are calculated on a constant currency basis and excluding the impact of divestitures and other amounts that are unusual, non-recurring items or unrelated to our ongoing operations. (3) Core Operating Profit represents net profit adjusted to exclude income tax expenses, the share of profit or l...
Source: businesswireindia.com